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Abstract 
Autotransporters, or type 5 secretion systems, are widespread surface proteins of Gram-negative 
bacteria often associated with virulence functions. Autotransporters consist of an outer membrane 
β-barrel domain and an exported passenger. In the poorly studied type 5d subclass, the passenger 
is a patatin-like lipase. The prototype of this secretion pathway is PlpD of Pseudomonas 
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aeruginosa, an opportunistic human pathogen. The PlpD passenger is a homodimer with 23 
phospholipase A1 (PLA1) activity. Based on sequencing data, PlpD-like proteins are present in 24 
many bacterial species. We characterized the enzymatic activity, specific lipid binding and 25 
oligomeric status of PlpD homologs from Aeromonas hydrophila (a fish pathogen), Burkholderia 26 
pseudomallei (a human pathogen) and Ralstonia solanacearum (a plant pathogen) and compared 27 
these with PlpD. We demonstrate that recombinant type 5d-secreted patatin domains have lipase 28 
activity and form dimers or higher-order oligomers. However, dimerization is not necessary for 29 
lipase activity; in fact, by making monomeric variants of PlpD, we show that enzymatic activity 30 
slightly increases while protein stability decreases. The lipases from the intracellular pathogens A. 31 
hydrophila and B. pseudomallei display PLA2 activity in addition to PLA1 activity. Although the 32 
type 5d-secreted lipases from the animal pathogens bound to intracellular lipid targets, 33 
phosphatidylserine and phosphatidylinositol phosphates, hydrolysis of these lipids could only be 34 
observed for FplA of Fusobacterium nucleatum. Yet, we noted a correlation between high lipase 35 
activity in type 5d autotransporters and intracellular lifestyle. We hypothesize that type 5d 36 
phospholipases are intracellularly active and function in modulation of host cell signaling events. 37 
 38 
Abbreviations 39 
4-Mu, 4- methylumbelliferone; 4-MuH, 4-methhylumbelliferyl heptanoate; AhPlA, Aeromonas 40 
hydrophila phospholipase autotransporter; BAM, β-barrel assembly machinery; BpPlA, 41 
Burkholderia pseudomallei phospholipase autotransporter; BS3, bis(sulfosuccinimidyl)suberate; 42 
CAPS, N-cyclohexyl-3-aminopropanesulfonic acid; CvPlA, Chromobacterium violaceum 43 
phospholipase autotransporter; DMSO, dimethyl sulfoxide; dpi, days post-infection; DTT, 44 
dithiothreitol; EDTA, ethylenediaminetetraacetic acid; FplA, Fusobacterium phospholipase 45 
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autotransporter; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; LB, lysogeny 46 
Broth; MES, 2-(N-morpholino)ethanesulfonic acid; MW, molecular weight; ND, not detectable; 47 
PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 48 
phosphatidylglycerol; PI, phosphatidylinositol; PlA, phospholipase autotransporter; PLA1, 49 
phospholipase A1; PLA2, phospholipase A2; PlpD, patatin-like protein D; POTRA, polypeptide 50 
transport associated; PS, phosphatidylserine; Psi, pounds per square inch; RFU, relative 51 
fluorescence unit; RsPlA, Ralstonia solanacearum phospholipase autotransporter; RT, room 52 
temperature; SEC, size exclusion chromatography; T5dSS, type 5d secretion system; T5SS, type 53 
5 secretion system; TLC, thin layer chromatography; Tris, tris(hydroxymethyl)aminomethane; 54 
VcPlA, Vibrio cholerae phospholipase autotransporter; wt, wild-type; ΔN, proteins lacking the 55 
N-terminal extension. 56 
 57 
INTRODUCTION 58 
Bacterial phospholipases comprise a diverse group of lipolytic enzymes belonging to the group of 59 
esterases. These enzymes hydrolyze glycerophospholipids and are classified based on the site of 60 
hydrolysis of their respective substrate into the subgroups phospholipase (PL)A, B, C and D. 61 
PLA is further split into PLA1 and PLA 2 depending on the site of ester bond hydrolysis at the 62 
sn-1 or sn-2 position of the glycerol moiety, respectively. PLA1 (EC 3.1.1.32) and PLA2 (EC 63 
3.1.1.4), belonging to the group of carboxyl ester acyl hydrolases, release a fatty acid from the 64 
glycerol backbone after hydrolysis, creating second-messenger lysophospholipids, often involved 65 
in intracellular signaling pathways (1-3). Also belonging to the group of carboxyl ester acyl 66 
hydrolases, lysophospholipase A removes the remaining fatty acid thereby neutralizing the toxic 67 
effect. Phospholipases are usually secreted or membrane-associated proteins and are, in many 68 
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cases, connected to virulence in a wide range of extracellular, vacuolar and intracellular 69 
pathogens. The actual role in infection can be manifold, ranging from membrane disruption as a 70 
means for competition, colonization benefits, generating nutrients, phagosomal escape or 71 
infection establishment to the formation of bioactive molecules or membrane remodeling (4-8) 72 
Type 5 secretion systems (T5SSs) are the most widespread secretion systems in bacteria (9) and 73 
several homologs of plpD have been identified by sequence similarity in various pathogenic 74 
bacteria, including Aeromonas hydrophila, Burkholderia pseudomallei, Ralstonia solanacearum, 75 
Vibrio cholerae and Fusobacterium nucleatum. The homolog found in F. nucleatum, FplA 76 
(Fusobacterium phospholipase autotransporter), was recently characterized as an outer 77 
membrane-associated phospholipase and thoroughly investigated in regard to enzymatic 78 
efficiency, inhibitors of lipase activity as well as lipid binding specificity (10). The Pseudomonas 79 
aeruginosa type 5d secretion system (T5dSS), called patatin-like protein D (PlpD), belongs to the 80 
family of patatin-like lipolytic enzymes (11). In accordance with the T5SS in general, PlpD 81 
possesses an N-terminal signal sequence for Sec-dependent translocation across the inner 82 
membrane and is dependent on the periplasmic chaperone SurA (12, 13) and presumably the 83 
BAM complex for integration of the C-terminal 16-stranded β-barrel domain into the outer 84 
membrane (9, 13-15). The β-barrel is connected by a single periplasmic polypeptide transport 85 
associated (POTRA) domain and a short linker to the N-terminal effector domain or passenger, 86 
which confers the lipolytic activity of PlpD. Once PlpD is integrated into the outer membrane, the 87 
N-terminal enzymatic domain is presumably translocated across the outer membrane through the 88 
C-terminal β-barrel domain similarly to classical autotransporters (16). Upon translocation of the 89 
passenger, the patatin-like moiety is cleaved and released into the extracellular space where it 90 
forms homodimers (17). However, not all PlpD-like patatin domains are cleaved and secreted; for 91 
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example in Fusobacterium nucleatum, the passenger domain can either remain attached to the β-92 
barrel domain or is cleaved but remains associated with the bacterial surface (10). 93 
Here we investigate, characterize and compare the passengers of T5dSSs found in several 94 
pathogenic bacteria individually and in context to already established data on phospholipase 95 
autotransporters (PlAs). We show that plpD homologs indeed encode for lipolytic enzymes and 96 
that oligomer formation is a conserved feature among all type 5d phospholipases tested. In spite 97 
of this, dimerization of the lipolytic domain of PlpD was found to be unnecessary for enzymatic 98 
hydrolysis of the non-native substrate 4-methylumbelliferyl heptanoate (4-MuH). Our results 99 
further show that the homolog from Ralstonia solanacearum, like PlpD (17), possesses 100 
PhosphoLipase Activity (PLA) 1, therefore belonging to the PLA1 carboxyl ester acyl hydrolases, 101 
whereas the homologs from Aeromonas hydrophila and Burkholderia pseudomallei possess both 102 
PLA1 and PLA2 activity, therefore being classified as phospholipase B (EC 3.1.1.5). We could 103 
also observe a correlation between temperature-dependent activity and host specificity as well as 104 
enzymatic efficiency and intracellular or extracellular pathogenic lifestyles. Although all 105 
phospholipases tested showed strong binding to phosphatidylserine (PS), the most abundant 106 
negatively charged lipid component in eukaryotic membranes (18) as well as to phosphatidic acid 107 
(PA) and to phosphatidylinositols (PI) in varying degrees, lipid hydrolysis could only be 108 
observed for FplA from Fusobacterium nucleatum and to a lesser degree in BpPlA from 109 
Burkholderia pseudomallei. Despite showing clear esterase activity towards the artificial 110 
substrate 4-MuH, determination of the specific lipid targets as well as the exact functions of PlAs 111 
in-vivo will need further investigation. 112 
 113 
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Materials and methods 114 
Chemicals were ordered from Sigma-Aldrich unless otherwise specified. ExpressPlus
TM
 4-20% 115 
SDS-PAGE Gels were ordered from GenScript. Primers were synthesized by ThermoFisher. 116 
Sequence alterations and successful plasmid construction were confirmed by Sanger sequencing 117 
using Eurofins Genomics. 118 
 119 
Bacterial strains and growth conditions 120 
E. coli TOP 10 (Invitrogen) was used for amplification of target plasmids and E. coli BL21Gold 121 
(DE3) (Novagen) were used for protein overexpression. Bacterial strains used in this study were 122 
grown in Lysogeny Broth (LB) (19), supplemented as required with kanamycin (50 µg/mL), at 123 
200 rpm and 37 ⁰C. For protein overexpression, bacteria were grown for 24 h in batches of 800 124 
mL at 30 ⁰C with aeration in autoinducing  ZYP-5052 medium (20) in the presence of 100 µg/mL 125 
kanamycin.  126 
 127 
Production of constructs for PlA production 128 
To produce the lipase domains of various PlAs, sequences encoding full-length PlpD (GenBank 129 
ID: AAG06727), AhPlA (AGM45846), BpPlA (ABA53592) and RsPlA (EAP74568) were 130 
codon-optimized for E. coli and synthesized by GeneArt (ThermoFisher Scientific). The 131 
sequences encoding the lipase domains were then subcloned into pET28a+ (Novagen) using 132 
Gibson assembly (21) to yield expression constructs containing a C-terminal histidine tag. We 133 
included the putative linker sequences in the constructs as PlpD lacking this stretch was reported 134 
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to be unstable (17). For VcPlA (AAF93770), the coding sequence was amplified directly from V. 135 
cholerae O1 El Tor N16961 genomic DNA and cloned into pASK-IBA3 (IBA GmbH). The 136 
lipase domain was subcloned into pET28a+ as above. To produce catalytic residue and 137 
dimerization interface point mutants, PCR-based site-directed mutagenesis was employed (22). 138 
The correctness of the constructs was determined by Sanger sequencing. Plasmids encoding the 139 
FplA lipase domain have been described before (10). All plasmids used in this study are 140 
summarized in Table 1. Primer sequences used for cloning are available upon request. 141 
 142 
Protein expression and purification 143 
pET28a+ plasmids containing the various expression constructs were amplified in E. coli TOP10 144 
and purified using the QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer`s 145 
manual. Purified plasmids were transformed into chemically competent E. coli BL21Gold (DE3) 146 
and transformants were screened for on LB plates supplemented with kanamycin. For protein 147 
production, transformants were grown overnight followed by fresh inoculation of autoinducing 148 
ZYP-5052 medium (20) with starter culture at a ratio of 1:200. Cells were harvested by 149 
centrifugation at 4000 x g for 10 min. Pelleted cells were resuspended in buffer (40 mM 150 
Na2HPO4, 400 mM NaCl, pH 8.0) supplemented with EDTA-free protease inhibitor cocktail 151 
(ThermoFisher Scientific), 1 mM MgCl2, 1 mM MnCl2, 0.1 mg/mL lysozyme and 2 µg/mL 152 
DNase 1 before application to a French pressure cell (Thermo IEC) for three passes at 16,000 psi 153 
for cell disruption. The cell debris was pelleted by centrifugation at 20,000 x g for 20 min at 4 ⁰C 154 
and the His-tagged target proteins present in the supernatant were subsequently applied to a 155 
HisTrap FF column (GE healthcare) and affinity purified using a NGC chromatography system 156 
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(BioRad) by a gradient elution with imidazole at a final concentration of 500 mM (40 mM 157 
Na2HPO4, 400 mM NaCl, 20-500 mM Imidazole, pH 8). Fractions containing the target proteins 158 
were confirmed to contain the correct protein by SDS-PAGE, concentrated using a centrifugal 159 
filter (Vivaspin 20, 30,000 MWCO PES) and applied to a HiPrep
™
 26/60 Sephacryl
®
 S-200 HR 160 
size exclusion column (GE) equilibrated with the protein running buffer (20 mM Tris, 300 mM 161 
NaCl, pH 7.5) for further purification. Fractions containing the target proteins were confirmed by 162 
SDS-PAGE, pooled and concentrated (Vivaspin 20, 30,000 MWCO PES). The concentration of 163 
the protein was determined based on the absorbance at 280 nm, and the solution was aliquoted in 164 
the presence of 10 % glycerol and flash-frozen in liquid nitrogen prior to storage at -80 ⁰C.  165 
 166 
Enzyme Kinetics 167 
The compound 4-MuH was used as a non-native substrate for determination of enzyme activity 168 
and enzyme kinetics. 4-MuH was solubilized in 100% dimethyl sulfoxide (DMSO). Target 169 
enzymes were diluted to the respective working concentrations in reaction buffer (20 mM 2-(N-170 
morpholino)ethanesulfonic acid (MES) pH 6/ tris(hydroxymethyl)aminomethane (Tris) pH 7.5/ 171 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 8.5/ Na2CO3 pH 9.5/ N-172 
cyclohexyl-3-aminopropanesulfonic acid (CAPS) pH 10.5, 50 mM NaCl, 0.5 % n-Octyl-β-D-173 
glucoside (BOG)), added to prewarmed 96-well black microplates (Greiner Bio-one) and 174 
enzymatic activity was determined by fluorescence measurement using a Synergy H1 microplate 175 
reader (Biotek). Fluorescence (excitation at 360 nm, emission read at 449 nm) was measured 176 
after initial orbital shaking for 5 sec at a constant temperature (25⁰C, 37⁰C or 45⁰C) at 2 min 177 
intervals for 20 min with 3 sec of orbital shaking before the individual reads. Cleavage of the 178 
ester bond of 4-MuH resulted in the release of 4-methylumbelliferone (4-Mu) and relative 179 
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fluorescence units measured at 449 nm were converted to product concentration using a 180 
previously established standard curve made with pure 4-Mu. Controls containing an equal 181 
amount of DMSO but no enzyme were included in all experiments and background values 182 
measured were subtracted from the data measured for the individual enzyme reactions. 183 
Enzymatic efficiency was calculated using Michaelis-Menten kinetics with the graphing and data 184 
analysis software from OriginLab (Massachusetts, USA). 185 
 186 
Test for phospholipase activity  187 
The EnzChek™ Phospholipase A1 Assay Kit and the EnzChek™ Phospholipase A2 Assay Kit 188 
(ThermoFisher Scientific) were used to test PLA1 and PLA2 activities according to the 189 
manufacturer’s instructions. These kits provide a fluorometric method for continuous 190 
measurement of PLA1 and PLA2 activity using the specific PLA1 and PLA2 substrates PED-A1 191 
and BODIPY® PC-A2, respectively. The final protein concentrations were adjusted for optimal 192 
signal output. Proteins from B. pseudomallei and A. hydrophila were used at a final concentration 193 
of 10 µM for detection of PLA1 activity and 50 µM for detection of PLA2 activity. Proteins from 194 
R. solanacearum were used at a final concentration of 50 µM and proteins from P. aeruginosa at 195 
a final concentration of 200 µM. The fluorescent signal measured upon substrate hydrolysis at the 196 
sn-1 (PLA1) and/or sn-2 (PLA2) position was converted to activity given in RFUs by comparison 197 
with a previously established standard curve using the PLA1/PLA2 stock solution provided by 198 
the manufacturer. Fluorescence (excitation at 470nm; emission read at 515nm) was measured 199 
using a Synergy H1 Microplate reader (BioTek). 200 
 201 
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Analytical Size Exclusion Chromatography 202 
Analytical size exclusion chromatography (SEC) was used to estimate the molecular weight 203 
(MW) and consequently the oligomerization status of solubilized P. aeruginosa PlpD as well as 204 
its homologs from A. hydrophila, R. solanacearum, B. pseudomallei and F. nucleatum by 205 
creating a calibration curve using MW standards (Biorad).The range of the molecular weight 206 
markers lies between 1.35 to 670 kDa (Vitamin B12 [1.35 kDa]; Myoglobin (horse) [17 kDa]; 207 
Ovalbumin (chicken) [44 kDa]; γ-globulin (bovine) [158 kDa]; Thyroglobulin (bovine) [670 208 
kDa]). At least 1 mg of sample was applied to a Superdex 200 Increase 10/300 GL gel filtration 209 
column (GE Life Science) using a NGC chromatography system (BioRad) in 20 mM Tris, pH 7.5, 210 
300 mM NaCl. Samples containing BpPlA were also run in the presence of 10 mM dithiothreitol 211 
(DTT). Resulting retention times of eluted proteins were converted to MWs using the calibration 212 
curve. 213 
 214 
Cross-linking 215 
For in vitro cross-linking, we followed the protocol described in (23). The buffer of all purified 216 
proteins was exchanged to 10 mM HEPES, pH 7.5. To this end, protein samples were diluted in 217 
fresh 10 mM HEPES buffer and subsequently concentrated again using Vivaspin 20 218 
concentrators (Sartorius) to a small volume. This procedure was then repeated once more. 219 
Bis(sulfosuccinimidyl)suberate (BS3) (ThermoFisher) was used as the cross-linking agent. BS3 220 
was dissolved to 50 mM in water and 0.5 µL of this solution was added to a final volume of 30 221 
µL 10 mM HEPES containing the target protein diluted to 1 mg/mL. The reaction was incubated 222 
at room temperature (RT) for 5 min and subsequently stopped by addition of 3 µL 1 M Tris, pH 223 
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7.5. Following a 15 min incubation at RT, 10 µL 4xSDS sample buffer was added and samples 224 
were heated to 95⁰C for 5 min prior to application to SDS-PAGE. 225 
 226 
Lipid binding 227 
Membrane Lipid Strips (Echelon) were used for determination of specific lipid targeting. 228 
Following the manufacturer`s protocol, lipid strips were blocked in PBS + 2% skimmed milk 229 
powder at 4 ⁰C overnight to avoid unspecific binding before addition of the protein of interest 230 
(PlpD S60A D207N/ AhPlA S67A D213N/ RsPlA S89A D231N: 0.5 mg/mL, BpPlA S230A 231 
D378N: 4 µg/mL) in PBS-T + 2 % skimmed milk for 1 h at RT. To avoid a loss in signal due to 232 
the lipolytic activity of the target proteins, we used double point mutant variants, where the 233 
catalytic dyad was mutated rendering the proteins catalytically inactive. Wash steps were 234 
performed with PBS-T. The primary antibody used was the mouse monoclonal THE
TM
 His Tag 235 
Antibody (GenScript) at a final concentration of 0.2 µg/mL. The secondary antibody used was 236 
CF®770 goat anti-mouse (Biotium) at a final concentration of 0.2 µg/mL. An Odyssey CLx 237 
Imaging system (LI-COR) was used for detection. 238 
 239 
Lipid hydrolysis assay 240 
Lipid hydrolysis assays were performed by incubation of 1 µM PlA with 0.5 mg/mL of the 241 
individual lipid in hydrolysis buffer (20 mM Na2CO3, 50 mM NaCl, 0.5 % BOG, pH 9.5) for 24 h 242 
at RT with aeration. After incubation, 1 volume of CHCl3 was added to the samples. The sample 243 
solvent was vortexed thoroughly and shortly centrifuged. The lipid containing CHCl3 phase was 244 
directly spotted on thin-layer chromatography (TLC) plates for lipid detection.  245 
 246 
Thin layer chromatography  247 
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HPTLC silica gel 60 F254 plates with concentration zones (Merck) were used for TLC to separate 248 
digested lipids. TLC plates were incubated at 100 ⁰C for one hour for activation by removal of 249 
any absorbed moisture before usage. Plates were allowed to cool down before samples were 250 
applied as small dots on the upper half of the concentration zone using glass micropipettes 251 
(Brand®). A sample volume of 10 µL was spotted and the sample solvent was allowed to 252 
evaporate completely before transferring the plate to the TLC chamber. A solvent system 253 
containing H2O, methanol and CHCl3 with a volume mixing ratio of 4:27:65 was used as mobile 254 
phase in the case of PE and PS, whereas the ratio was adjusted to 4:28:65 in the case of PI(4)P 255 
and the soy lipid extract. The atmosphere within the TLC chamber was saturated for at least one 256 
hour prior to plate application. The plate was removed from the TLC chamber before the mobile 257 
phase could reach the top of the plate and air dried until complete evaporation of the solvent. 258 
Exposing the TLC plate to iodine vapor was used as to visualize separated lipids. Iodine crystals 259 
were placed into the iodine chamber 24 h before use to assure complete saturation of the chamber 260 
with iodine vapor. After staining, the plates were digitized by scanning. 261 
 262 
Toxicity assays using Galleria mellonella 263 
Galleria mellonella TruLarv® larvae were obtained from BioSystems Technology. The direct 264 
toxic effect of PlAs was tested by intrahemocoelic injection (24) of 20 µL purified protein of 265 
varying concentrations in PBS using a single syringe infusion pump (Cole-Parmer). The control 266 
groups were injected with either the respective, catalytically dead enzyme or 20 µL PBS. Larvae, 267 
each weighing 0.2-0.3 g, were kept at 37⁰C for 5 days and were checked for stages of 268 
disease/survival in a 24 h interval. Dead larvae, detectable by strong melanization and lack of 269 
movement, were removed from the stock of surviving larvae. Percentage survival was plotted 270 
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against concentration for each of the concentration of PlA tested, and lethal dose (LD50) values 271 
were calculated using origin (25). 272 
 273 
Bioinformatics 274 
Bioinformatic analyses were mostly performed using online tools at the Max Planck Institute 275 
Bioinformatics Toolbox (26). Sequence searches were performed using BLAST or PSI-BLAST 276 
(27) using the PlpD or BpPlA sequences as queries. Sequence alignments were performed with 277 
Clustal Ω (28) followed by manual editing. Secondary structure prediction was done using Ali2D 278 
(26). For predicting signal sequences, SignalP 4.1 (29) and Phobius (30) were employed. In some 279 
cases (e.g. AGM45846), the start codon was apparently mis-annotated; therefore, manual 280 
scanning of the upstream sequence was instigated until a well-predicted in-frame signal peptide 281 
was located. 282 
 283 
Mass Spectrometry 284 
In-gel trypsin digest of gel-fractionated target proteins were analyzed by mass spectrometry using 285 
the proteomic facilities at the University of Oslo 286 
(https://www.mn.uio.no/ibv/english/research/sections/bmb/research-groups/enzymology-and-287 
protein-structure-and-function/proteomics-thiede/proteomics-service/) 288 
 289 
RESULTS 290 
Sequence analysis of passengers of PlpD homologs 291 
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Many species of bacteria contain genes homologous to plpD, including members of the 292 
Proteobacteria, Bacteroidetes, Firmicutes and Chlorobi (11). The passengers of the proteins 293 
encoded by these genes represent a patatin-like lipase domain and are all highly similar to PlpD. 294 
An alignment of selected lipase domains demonstrates this similarity, especially at the level of 295 
predicted secondary structure (Figure 1). The alignment pinpoints the conserved catalytic dyad 296 
(serine, aspartic acid) as well as the few residues forming the oxyanion hole, suggesting that they 297 
all possess lipase activity, similar to PlpD and FplA (10, 17). Following the convention 298 
established for FplA, we have named this group of proteins Phospholipase Autotransporters 299 
(PlAs), and included the first two letters of the binomial names to designate the source species. 300 
Thus, the PlA from Aeromonas hydrophila is named AhPlA, the PlA from Vibrio cholerae 301 
VcPlA, and so forth. To avoid confusion in the literature, we have kept the name PlpD for the P. 302 
aeruginosa protein, and FplA for the Fusobacterium nucleatum PlA.  303 
All PlAs have a predicted signal peptide at the N-terminus. For most, this is between 18 and 23 304 
residues in length, a standard length for Sec-dependent signal peptides. However, CvPlA (from 305 
Chromobacterium violaceum), RsPlA (from Ralstonia solanacearum) and the PlA from 306 
Burkholderia pseudomallei (BpPlA) have longer signal sequences, 29, 30 and 36 residues, 307 
respectively (Figure 1B). Some autotransporters of other classes also have extended signal 308 
sequences (31, 32), and the signal peptides of BpPlA and CvPlA are reminiscent of those. 309 
Most of the proteins shown in Figure 1B contain just the lipase domain preceding the putative 310 
linker sequence connecting to the periplasmic POTRA domain. However, some PlAs have an N-311 
terminal extension. FplA has a 40-residue extension (10), but BpPlA has a significantly longer 312 
extension (155 residues). This region contains a number of alanine and serine-rich repeats (Figure 313 
1B). Such extensions are found in all B. pseudomallei PlAs, though the number of these repeats 314 
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varies between strains (Figure S1). Similar extensions are also present in the closely related B. 315 
mallei, but other members of the Burkholderia genus have PlAs with significantly shorter 316 
extensions (Figure S1).  317 
 318 
Predicted plpD homologs encode for a type 5d phospholipase autotransporters 319 
The sequences coding for the passenger of AhPlA, BpPlA, PlpD, RsPlA and VcPlA lacking the 320 
N-terminal signal sequence were cloned into the expression plasmid pET28+, which provides a 321 
C-terminal His-tag, and expressed in E. coli BL21Gold(DE3). The proteins were then purified by 322 
affinity and size exclusion chromatography. In contrast to the other PlAs, VcPlA was only 323 
produced as inclusion bodies. As our attempts at refolding VcPlA failed (data not shown), we did 324 
not analyse this protein further. For the other PlAs, esterase activity was determined by 325 
continuous fluorometric measurement using the non-native lipid substrate 4-MuH (Figure 2A). 326 
All purified proteins were active and esterase activity could be shown for PlpD as well as all 327 
homologs with a functional catalytic dyad (Table 2; Figure 2A). Although the Michaelis constant 328 
(Km) was at a comparable level for most of the tested PlAs, the substrate turnover rates (kcat) 329 
varied significantly ranging from a comparatively low value of kcat ~0.1 s
-1
 and ~0.3 s
-1
 in the 330 
case of the RsPlA passenger and the PlpD passenger, respectively, to a kcat ~21 s
-1
 for the BpPlA 331 
passenger. During purification, we noticed some apparent degradation of the PlAs, particularly in 332 
the case of RsPlA (Figure S2). We also observed minor degradation products in the case of 333 
BpPlA (Figure S2). We were concerned that this might affect the enzyme activity; therefore, we 334 
mapped the degradation site to the N-terminus of RsPlA by mass spectrometry (Figure S2). We 335 
then produced a protein, corresponding to the degradation product, lacking the N-terminal 336 
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extension (RsPlA ΔN). Deletion of the N-terminal extensions of the BpPlA and RsPlA 337 
passengers, resulting in the proteins BpPlA ΔN and RsPlA ΔN, led only to a slight decrease in 338 
enzymatic efficiency by roughly a factor of two (Table 2), therefore, we assumed that the 339 
degradation of RsPlA has no major effect on the protein`s enzymatic activity. Upon the dual 340 
mutation of the active site Serine (Ser→Ala) and Aspartate (Asp→Asn) of the catalytic dyad, 341 
enzymatic activity decreased significantly or was completely abolished in all PlAs (Table 2).   342 
 343 
PlAs display enzymatic activity across a broad pH and temperature range 344 
Enzyme kinetics at a range of biologically relevant temperatures and pH values were performed 345 
to determine the optimum conditions for activity of the purified passengers of PlpD, AhPlA, 346 
BpPlA/BpPlA ΔN and RsPlA/RsPlA ΔN (Figure 2A, Figure S3).  347 
Enzymatic activity could be detected along a broad pH range (pH 6 – pH 10) for all PlAs with a 348 
pH optimum for the different proteins between pH 8.5 and pH 9.5. A clear drop in activity could 349 
be observed at pH values above 9.5 or below 8 (Figure S3). In the case of BpPlA, the N-terminal 350 
extension was important in oligomer formation (see below). No significant difference in pH-351 
dependent activity could be observed between BpPlA and BpPlA ΔN. RsPlA ΔN was included in 352 
the experiment after the observation of a degradation product of RsPlA during SDS-gel 353 
fractionation (Figure S2). RsPlA ΔN showed a decrease in enzymatic efficiency compared to the 354 
RsPlA wild-type (wt) protein at all points, ranging from a factor of  two at pH 6 to a factor of 10 355 
at pH 10. 356 
PlpD, BpPlA and BpPlA ΔN are also active at a broad temperature spectrum ranging from 25-45 357 
⁰C with an optimum in enzymatic efficiency of 1.8 x 103 s-1 M-1, 6.9 x 105 s-1 M-1  and 2.6 x 105 358 
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s
-1
 M
-1
 at 37⁰C, respectively (Table 2). A decrease in enzymatic efficiency is correlated with an 359 
increase in temperature in the case of AhPlA and RsPlA, with the highest enzymatic activity of 360 
8.8 x 10
4
 s
-1
 M
-1
 (AhPlA) and 7.9 x 10
3
 s
-1
 M
-1
 (RsPlA) at 25 ⁰C (Table 2). BpPlA ΔN showed 361 
only a minor decrease in enzymatic activity by roughly a factor of two when compared to BpPlA 362 
wt. RsPlA ΔN on the other hand showed no detectable activity at 45 ⁰C (Figure S3).  363 
 364 
PlAs from A. hydrophila and B. pseudomallei have phospholipase B activity 365 
Phospholipase activities are subdivided into phospholipase A, B, C and D according to the 366 
specific site of hydrolysis on a phospholipid. In this context, all PlAs were tested for PLA1 and 367 
PLA2 activity using PLA1 and PLA2-specific substrates.  368 
All PlAs showed activity towards the PLA1-specific substrate PED-A1 (Figure 2B). A strong 369 
activity was measured for BpPlA (>4 Relative Fluorescence Units (RFUs)), RsPlA (>4 RFUs) 370 
and AhPlA (>3 RFUs) at a molecular concentration of 20 µM, 50 µM and 20 µM, respectively. 371 
PlpD on the other hand showed a comparable activity of >6 RFUs only after 1h and at a final 372 
concentration of 200 µM. The lower activity observed for PlpD is in agreement with previous 373 
results, where the PLA1 activity of PlpD, although clear, was significantly lower than the positive 374 
control (17). PLA1 activity increased with time for all PlAs, whereas the catalytically impaired 375 
variants of the same proteins (AhPlA S67A D213N, BpPlA S230A D378N, PlpD S60A D207N 376 
and RsPlA S89A D231N) displayed no PLA1 activity (Figure 2B). 377 
The PlAs from A. hydrophila and B. pseudomallei also displayed PLA2 activity (Figure 2B). A 378 
high activity (AhPlA ~7 RFUs; BpPlA >4 RFUs) was evident in both cases, whereas no activity 379 
could be detected for RsPlA or PlpD. 380 
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 381 
Binding to phosphatidylserine is conserved in PlAs  382 
After confirmation of lipolytic activity for as well as enzymatic characterization of all PlAs using 383 
the non-native lipid substrate 4-MuH, we wanted to identify the native interaction partners of the 384 
individual proteins. To this end, lipid binding assays were performed individually for all PlAs 385 
using lipid-coated strips covering the most abundant phospholipids present in eukaryotic and 386 
prokaryotic cells (Figure 3). We used the catalytically inactive versions of the respective PlAs to 387 
avoid loss of signal due to hydrolysis of the target lipids bound to the lipid strips. We also tested 388 
the binding of wt PlpD to the lipid strip and did not observe any significant differences to the 389 
mutant, thus confirming that mutation of the catalytic dyad has no major effect on lipid binding 390 
(Figure S4).  391 
AhPlA S67A D213N, BpPlA S230A D378N and RsPlA S89A D231N all bound PS with 392 
relatively high affinity compared to the other phospholipids tested, as well as to PA, although less 393 
strongly (Figure 3). Our results for PlpD were qualitatively similar to those observed previously 394 
(17). None of the PlAs tested showed binding towards phosphatidylethanolamine (PE), 395 
phosphatidylcholine (PC), phosphatidylglycerol (PG), or phosphatidylinositol (PI) without 396 
additional phosphorylation of the inositol group. PI 4-phosphate (PI(4)P), PI (4,5)-biphosphate 397 
(PI(4,5)P2) and PI (3,4,5)-triphosphate (PI(3,4,5)P3) binding was observed for PlpD S60A D207N 398 
and AhPlA S67A D213N. BpPlA S230A D378N only bound to PI(4)P, whereas no binding was 399 
detected between any phosphoinositol and RsPlA S89A D231N. AhPlA S67A D213N was the 400 
only one of the tested proteins to bind to cardiolipin in our experiments. We did not see any 401 
binding of PlpD to cardiolipin, in contrast to what was observed both for PlpD (17) and FplA 402 
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(10). Although FplA did bind to cardiolipin, it did so only at high lipid concentrations of (10). 403 
We suggest that PlA binding to cardiolipin might be an artifact, e.g. due to dose-dependent 404 
unspecific binding.  405 
Thin layer chromatography 406 
To ascertain that the lipids that bound to PlAs are also targets for hydrolysis, we perfomred 407 
enzymatic digestions of purified lipids. We chose PS and PI(4)P, as these were targeted by most 408 
PlAs in the lipid overlay assays. We also included PE as a non-target lipid. Surprisingly, only 409 
FplA showed clear hydrolytic activity towards both PE and PS, where one of two bands 410 
disappeared during incubation with the active enzyme. No activity was detected towards PI(4)P 411 
for any of the lipases (Figure 4A-C).  412 
As we did not observe any hydrolysis with specific lipids, we then tested a mix of lipids. For this, 413 
we used a soy bean polar lipid mix (PC 45.7 %; PE 22.1 %; PI 18.4 %; PA 6.9 %; unknown 414 
lipids 6.9 %; Avanti). 415 
The soy lipid extract showed three distinctive bands in the absence of any PlA. When incubated 416 
with FplA, the upper and the lower band disappeared or at least a strong reduction in intensity 417 
was observed (Figure 4D). Similarly to FplA, also BpPlA showed hydrolytic activity towards the 418 
upper band present in the soy lipid extract. Although far less pronounced compared to FplA, a 419 
reduction in intensity of the upper band could be observed (Figure 4D) which is absent in BpPlA 420 
S230A D378N. The other PlAs showed no detectable activity towards any of the major lipid 421 
species tested at the given concentration (Figure 4D). 422 
 423 
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Formation of homodimers is conserved within PlAs 424 
The PlpD passenger structure has an α/β hydrolase fold with a twisted six-stranded central β-425 
sheet surrounded by eight major helices, which forms homodimers due to the direct interaction 426 
between the two hydrophobic α7-helices of neighbouring molecules (17) (Figure 5A). Sequence 427 
alignments of plpD and its homologs revealed that the interaction interface is conserved within 428 
the tested PlAs (Figure 5A). To investigate the potential oligomerization of the purified 429 
passengers, we employed SEC in combination with cross-linking experiments using BS3. The 430 
estimated molecular sizes of the monomeric target proteins were determined using Protparam 431 
(ExPASy) and are shown in Table 3. 432 
The MW estimated by SEC for the purified passengers of PlpD, AhPlA, RsPlA and FplA20-431 (10) 433 
in solution were 69 kDa, 62 kDa, 65 kDa and 83 kDa, respectively (Figure 5C). The estimated 434 
MWs correspond to approximately twice that of the MWs of the monomeric proteins (Figure 5D). 435 
Mutation of the catalytic dyad residues, resulting in the catalytically impaired AhPlA S67A 436 
D213N and RsPlA S89A D231N, had no significant effect on the MW compared to the 437 
respective wt constructs (Table 3), demonstrating that the introduced mutations do not have an 438 
effect on dimerization and folding of mutant proteins.  439 
In the case of BpPlA, we observed a very large protein aggregate under oxidizing conditions. 440 
Because BpPlA contains a single cysteine in the N-terminal extension, we reasoned that the 441 
aggregation may be due to disulphide cross-linking. To test this, we repeated the experiment in 442 
the presence of the reducing agent DTT. Under these conditions, the MW of the BpPlA passenger 443 
was estimated to be approximately four times the size of the monomeric BpPlA, at 191 kDa 444 
(Figure 5C & D). The MW of the catalytically impaired BpPlA S230A D378N was determined to 445 
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be in a similar range with an estimated MW of 178 kDa. Deletion of the N-terminal extension, 446 
resulting in the truncated protein BpPlA ΔN, resulted in loss of aggregation and a significant 447 
decrease in molecular size with an estimated MW of 60 kDa in solution, corresponding to a 448 
dimeric protein. Thus, the N-terminal extension promotes potential dimer-dimer formation but is 449 
not needed for homodimer formation. 450 
The amine-amine crosslinker BS3 was used to confirm multimer formation of the purified PlAs. 451 
Successful cross-linking of all PlAs was detected after addition of BS3, whereas no SDS-resistant 452 
multimer formation was observed in absence of the cross-linking agent (Figure 5B). A clear 453 
cross-linking product at a MW of approximately 100 kDa could be detected for the PlpD, RsPlA, 454 
AhPlA and FplA passengers. The additional band at 25 kDa in the case of RsPlA shows the 455 
previously mentioned RsPlA degradation product. The BpPlA passenger sample showed a 456 
prominent band roughly at 200 kDa as well as minor bands at approximately 150 kDa and 120 457 
kDa. In the case of BpPlA pass ΔN one distinctive cross-linking product at approximately 100 458 
kDa could be detected, which corresponds to the bands of dimeric PlpD, RsPlA and AhPlA. The 459 
identity of the bands indicating formation of multimers were confirmed by MS (Figure S5) 460 
 461 
PlpD can be stably monomerised by disrupting the hydrophobic dimerization interface 462 
To investigate the role of homodimer formation in enzyme activity, specific residues at the 463 
reported interaction interface on helix α7 (Figure 6A) were substituted, resulting in the mutants 464 
PlpD M249E and PlpD I253A M256D. Both mutants resulted in stable monomeric protein as 465 
shown by SEC (Figure 6B) and BS3 cross-linking (Figure 6C). The wt PlpD showed a prominent 466 
band at approximately 100 kDa following incubation with BS3 during the cross-linking 467 
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experiment which is absent in the monomeric PlpD I253A M256D. In PlpD M249D a faint band 468 
is still visible at aprroximately 100 kDa. Independent of BS3, both monomeric proteins showed 469 
an additional band at 25 kDa which is absent in the PlpD dimer. These are of a similar size as the 470 
degradation product of RsPlA, which led us to assume that the additional band is a degradation 471 
product of the PlpD monomers. SEC provided corroborating results for the mutants being 472 
monomers, where PlpD M249E as well as PlpD I253A M256D eluted at an estimated size of 35 473 
kDa, the expected size of the monomer (Table 4). By contrast, the PlpD passenger eluted at an 474 
estimated MW of 69 kDa, corresponding to a dimeric protein.  475 
 476 
Homodimer formation by PlpD is not necessary for lipase activity in vitro 477 
The monomeric PlpD variants were tested for alteration or loss in enzymatic activity using 4-478 
MuH. Both PlpD M249E and PlpD I253A M256D showed slightly increased lipase activity at 479 
lower temperatures compared to the homodimer, demonstrating that the monomeric variants are 480 
enzymatically active (Table 5). Although showing comparable enzymatic efficiencies at lower 481 
temperatures, PlpD monomers showed a marked decrease in enzymatic activity with increasing 482 
temperatures, which was not observed with the PlpD dimer, as it was stably active up to 45 ⁰C 483 
(Figure 7). The same trend was observed when testing for PLA1 activity. When comparing PLA1 484 
activity of the proteins, a slight but clear increase in activity of the monomeric proteins PlpD 485 
M249E (˂3 RFU) and PlpD I253A M256D (˂3 RFU) compared to dimeric PlpD (˂1 RFU) was 486 
detected at all time points (Figure 7).  487 
 488 
Low toxic effect of AhPlA and BpPlA on survival of Galleria mellonella 489 
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The insect G. mellonella belongs to the order Lepidoptera and the family Pyralidae (Scoble M. 490 
Classification of the Lepidoptera Oxford University Press, 1995). The use of the caterpillar larvae 491 
of G. mellonella as an animal model for microbial infections attracts increasing attention due to 492 
remarkable similarities of their innate immune response with the immune response in vertebrates 493 
(33)  while being inexpensive and easy to handle (34). 494 
The direct toxic effect of PlAs was tested by intrahemocoelic injection of purified protein into 495 
Galleria mellonella larvae. The mortality rate of larvae as response to injection with BpPlA and 496 
AhPlA were dose dependent. Whereas no toxic effect of either of the two PlAs was observed 5 497 
days post-infection (dpi) with 2 µg/g, an increase of dosage to 20 µg/g resulted in a mortality rate 498 
of 25 % in the case of BpPlA and 19 % in the case of AhPlA. By increasing the dosage to 200 499 
µg/g, mortality rates also increased to 40 % for BpPlA and 22 % for AhPlA. 500 
Neither PlpD (1 mg/g) nor FplA (125 µg/g) showed any toxic effect, even at very high 501 
concentrations (Table S1).  502 
 503 
 504 
DISCUSSION  505 
 506 
The type 5d subclass of autotransporters was described almost 10 years ago, with PlpD from 507 
Pseudomonas aeruginosa as the prototype (11). PlpD consists of a C-terminal outer membrane-508 
embedded 16-stranded β-barrel connected to a single POTRA domain, a short linker and an N-509 
terminal passenger. The passenger belongs to the family of bacterial patatin-like phospholipases, 510 
forming homodimers upon translocation across the outer membrane and release into the 511 
extracellular space (17). T5SSs as well as bacterial phospholipases are important pathogenicity 512 
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factors employed by many organisms during infection. Despite this potential biological relevance, 513 
little is known about PlpD and little to no information is available on PlpD homologs in other 514 
organisms. FplA from Fusobacterium nucleatum is the lone exception, which was recently 515 
characterized (10) .  516 
Based on sequence alignments, homologs of PlpD found in A. hydrophila, B. pseudomallei and R. 517 
solanacearum were tested and confirmed for esterase activity due to the recognition and 518 
subsequent hydrolysis of the artificial substrate 4-MuH. Like PlpD (11) and FplA (10), all tested 519 
passengers share a conserved serine-aspartate catalytic dyad necessary for enzymatic activity, as 520 
demonstrated by loss of activity when these residues are mutated. Although highly similar in 521 
structure and primary sequence, RsPlA, BpPlA and FplA have distinctive differences when 522 
compared to PlpD, e.g. the N-terminal extension of their respective passengers. Deletion of the 523 
N-terminal extension had almost no effect on the enzymatic activity. We therefore speculate that 524 
the N-terminal extensions could have a role in folding or structural stabilization or possibly in 525 
binding to target molecules or membranes. This is supported by the fact that the deletion of the 526 
N-terminal extension in R. solanacearum led to a decrease in thermal stability at increasing 527 
temperatures, as well as the fact that PlAs from B. pseudomallei with intact N-termini form 528 
higher molecular-weight complexes, as demonstrated by SEC and cross-linking experiments. 529 
This observation indicates a role for the extension in multimer formation. The particularly long 530 
N-terminal extensions found in the proteins from the highly virulent B. pseudomallei and B. 531 
mallei, combined with the conspicuous lack in orthologs from less pathogenic Burkholderia 532 
species, also points to a role in virulence. Multimer formation by self-association of proteins can 533 
confer structural or functional advantages, e.g. increased stability, heightened substrate 534 
specificity or regulation of enzymatic activity. Although homodimer formation is a conserved 535 
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feature of the tested PlAs, it is not needed for enzyme activity of PlpD. Both mutants, PlpD 536 
M249E and PlpD I253A M256D, were enzymatically active in their monomeric form. When 537 
exposed to an increase in temperature, however, the monomers show a drastic decrease in 538 
enzymatic efficiency, while the activity of the dimer stays at a comparable level over a broad 539 
temperature range. Dimerization of PlpD therefore increases stability and assures enzymatic 540 
activity over a broad temperature range, but we cannot exclude that the lower activity of the 541 
dimer also plays another role. Homodimer formation may result in conformational changes, 542 
which enables the highly specific binding of individual lipid targets or the generation of sites for 543 
allosteric regulation, allowing the binding of cofactors to non-substrate sites (35, 36). 544 
Upon translocation across the outer membrane, passengers can either stay attached to the 545 
membrane or be cleaved off and released into the extracellular space, as has been reported for 546 
PlpD (11). FplA from F. nucleatum is cleaved in some strains, but not released from the 547 
membrane (10). Although not impossible, the fact that all tested PlA passengers form 548 
homodimers or, in the case of BpPlA, complexes of more than 2 subunits, makes it unlikely that 549 
PlAs in general stay surface-attached and suggests protein cleavage upon translocation across the 550 
outer membrane. Especially the probable dimer-dimer formation by BpPlA seems unlikely to 551 
take place while still attached to the membrane. If the lipase domains are indeed released by 552 
proteolysis, this is most likely facilitated by an external protease, based on the observation that 553 
neither the PlpD nor the FplA passenger is cleaved after heterologous expression in E. coli (10, 554 
11).   555 
Interestingly, the activities of the various type 5d lipases towards 4-MuH are correlated with the 556 
lifestyle of the source bacteria: PlAs from mainly extracellular pathogens such as P. aeruginosa 557 
had comparatively low activity, whereas the intracellular pathogens F. nucleatum (10) and B. 558 
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pseudomallei displayed much higher activity. PlAs from the extracellular pathogens P. 559 
aeruginosa and R. solanacearum (37-39) showed a low enzymatic efficiency when exposed to 4-560 
MuH compared to those from the intracellular pathogens B. pseudomallei (40), F. nucleatum (10) 561 
and the facultative intracellular pathogen A. hydrophila (41, 42). This activity difference may 562 
indicate a primarily intracellular role for the type 5d phospholipases. Although further research 563 
into this topic is necessary, possible roles may include interference with signal transduction 564 
pathways, similar to the case of the P. aeruginosa ExoU (43, 44), or phagosomal escape into the 565 
cell cytosol similar to other phospholipases (7, 8, 45). However, given the low activity of PlAs 566 
towards major lipids, the latter does not seem to be a very likely function of PlAs. 567 
In spite of strong PS binding by all tested proteins, hydrolysis of the purified lipids could only be 568 
observed in the case of FplA incubated with PE or PS. PS is the most abundant negatively 569 
charged phospholipid in eukaryotic cells and is largely spatially restricted to the cytosolic side of 570 
the cell membrane (18). In bacterial membranes, PS is less abundant or absent, but nonetheless an 571 
important cytosolic precursor in the synthesis of essential membrane lipids like PE in E. coli 572 
through the two enzymes phosphatidylserine synthase and phosphatidylserine decarboxylase (46). 573 
Next to its role in PE synthesis, PS is also a known target lipid for a range of specific membrane 574 
binding proteins (47). Thus, PS might not be a target for digestion by PlAs, but might be a 575 
binding target that guides PlAs to membranes where they then act on their specific target(s). In 576 
our digestion assays, only the highly active lipases FplA and BpPlA had any detectable activity. 577 
The in vivo targets of PlAs thus still remain to be discovered.  578 
It should be noted that FplA only removed one of several PS or PE bands, suggesting that the 579 
acyl chain identity could also affect target specificity. The hydrophobic cleft of PlpD can 580 
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accommodate C18-C20 acyl chains (17).Thus, the size of the chain and the presence and position 581 
of unsaturated bonds could affect lipid specificity.  582 
None of the tested PlAs showed hydrolytic activity towards PI(4)P at the given concentrations, 583 
despite previous studies suggesting phosphorylated PIs might be the targets of PlAs (10, 17). PIs 584 
are most abundant in the cytosolic membrane leaflets and play essential roles in eukaryotes. 585 
These roles include their function as membrane-located interaction partners for a wide range of 586 
proteins involved in cellular signal transduction cascades (48, 49). Though we did not observe 587 
hydrolysis of PI(4)P in our experiments, we did not test other PI species. Therefore, we cannot 588 
exclude other phosphorylated PI species as possible interaction partners in vivo..  589 
The lack of PlA-mediated PE or PS digestion, with the exception of FplA, makes it unlikely that 590 
the tested PlAs target major lipid species. Nonetheless, the tested PlAs may target minor lipid 591 
species or may need yet unidentified cofactors for full activity not present in the commercially 592 
available lipid extracts. This idea is supported by the fact that hydrolysis of certain lipids present 593 
in the soy extract was observed after incubation with FplA and BpPlA. Especially BpPlA, which 594 
did not show hydrolytic activity towards purified PE, PS or PI(4)P, showed lipolytic activity 595 
when confronted with a mixture of lipids present in the soy extract. 596 
When it comes to the specific cleavage site engaged by the tested phospholipases, RsPlA cleaves 597 
at the sn-1 position, therefore belonging to the group of 1-acyl hydrolyses, as previously shown 598 
for PlpD (17) The passengers of BpPlA and AhPlA possess both PLA1 and PLA2 activity, 599 
therefore belonging to the group of phospholipases B. Interestingly, only the PlAs with PLB 600 
activity demonstrated any toxicity in the Galleria model. Even then, toxicity required very high 601 
protein concentrations, demonstrating that PlAs are most likely not membrane-disrupting toxins. 602 
28 
 
This is fully in line with our in vitro observations and suggests that PlAs play much more subtle 603 
roles in vivo. Taken together, the higher activity of PlAs from intracellular pathogens, the 604 
apparently narrow substrate range, and the low toxicity of PlAs point towards a very specific, 605 
possibly intracellular role for these proteins in virulence. We therefore propose a role in 606 
modulating host signaling events during intracellular infections as a hypothesis for future 607 
research.    608 
 609 
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Tables 748 
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Table 1. Plasmids used in this study 749 
Name Insert Comments Source 
pDJSVT84 FplA20-431 For production of FplA lipase domain; 
includes C-terminal His tag 
Casasanta, 
Yoo (10) 
pET28a+ - Expression vector with T7 promoter  Novagen 
pET28-
AhPlAPass 
AhPlpA24-333 For production of Aeromonas hydrophila PlA 
lipase domain; includes C-terminal His tag 
This study 
pET28-
AhPlAPass 
S67A D213N 
AhPlpA24-333 For production of catalytically inactive 
Aeromonas hydrophila PlA lipase domain; 
includes C-terminal His tag 
This study 
pET28-
BpPlAPass 
BpPlA37-496 For production of Burkholderia pseudomallei 
PlA lipase domain; includes C-terminal His 
tag 
This study 
pET28-
BpPlAPass 
S230A D378N 
BpPlA37-496 For production of catalytically inactive 
Burkholderia pseudomallei PlA lipase 
domain; includes C-terminal His tag 
This study 
pET28-
BpPlAPassΔN 
BpPlA190-496 For production of Burkholderia pseudomallei 
PlA lipase domain lacking N-terminal 
extension; includes C-terminal His tag 
This study 
pET28-
PlpDPass 
PlpD19-331 For production of PlpD lipase domain; 
includes C-terminal His tag 
This study 
pET28-
PlpDPass 
I253A M256D 
 
PlpD19-331 For production of PlpD lipase with mutations 
in dimerization interface; includes C-terminal 
His tag 
This study 
pET28-
PlpDPass 
M294E 
 
PlpD19-331 For production of PlpD lipase with mutation 
in dimerization interface; includes C-terminal 
His tag 
This study 
pET28-
PlpDPass 
S60A D207N 
 
PlpD19-331 For production of catalytically inactive PlpD 
lipase domain; includes C-terminal His tag 
This study 
pET28-
RsPlAPass 
RsPlA31-352 For production of Ralstonia solanacearum 
PlA lipase domain; includes C-terminal His 
tag 
This study 
pET28-
RsPlAPass 
S85A D231N 
RsPlA31-352 For production of catalytically inactive 
Ralstonia solanacearum PlA lipase domain; 
includes C-terminal His tag 
This study 
pET28-
RsPlAPassΔN 
RsPlA48-352 For production of Ralstonia solanacearum 
PlA lipase domain lacking N-terminal 
extension; includes C-terminal His tag 
This study 
pET28-
VcPlAPass 
VcPlA22-339 For production of Vibrio cholerae PlA lipase 
domain; includes C-terminal His tag 
This study 
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 750 
Table 2. Comparison of the enzymatic efficiency of all tested PlAs at pH 9 and at optimal 751 
temperatures. Shown are the Michaelis-Menten Kinetics using the graphing and data analysis 752 
software from OriginLab (Massachusetts, USA). ND=Not detectable. 753 
Passenger Tmp. (⁰C) kcat (s
-1
) Km (µM) kcat/Km (s
-1
 M
-1
) 
PlpD19-331 37 0.3 ± 0.04 166 ± 44 1.8 x 10
3 
± 0.5 x 10
3
 
PlpD19-331 S60A D207N 37 ND ND ND 
AhPlA24-333 25 10.6±1.1 120±25 8.8 x 10
4
 ± 2 x 10
4
 
AhPlA24-333 S67A D213N 25 0.005
 
± 0.003 27 ± 50 1.8 x 10
2
 ± 3.6 x 10
2
 
BpPlA37-496 37 21.2 ± 1.9 31 ± 9 6.9 x 10
5 
± 2 x10
5
 
BpPlA37-496 S230A D378N 37 ND ND ND 
BpPlA190-496 37 12 ± 1 47 ± 10 2.6 x 10
5
 ± 0.6 x 10
5
 
RsPlA31-352 25 0.5 ± 0.04 62 ±13 7.9 x 10
3
 ± 1.8 x 10
3
 
RsPlA31-352 S89A D231N 25 ND ND ND 
RsPlA48-352 25 0.1 ± 0.005 34 ± 6 2.8 x 10
3
 ± 0.5 x 10
3
 
FplA20-431 * 25 55 ± 4 19.6 ± 5 2.8 x 10
6
 ± 0.7 x 10
6
 
*Casasanta et al., 2017 754 
 755 
 756 
Table 3. Estimated molecular weight of all tested PlAs based on the retention time of SEC. The 757 
MW of the monomeric proteins are shown for comparative reason and were calculated in 758 
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Protparam based on the respective amino acid sequences. The deletion of the N-terminal 759 
extension is indicated as ΔN. The reducing agent DTT was added at 10 mM in the case of the full 760 
length passenger of BpPlA due to the presence of a cysteine in the N-terminal extension of this 761 
protein. 762 
Protein Est.MW 
[kDa] 
Monomer [kDa] 
PlpD19-331 69 35 
PlpD19-331 S60A D207N 88 35 
PlpD19-331 M249E 35 - 
PlpD19-331 I253A M256D 35 - 
AhPlA24-333 62 34 
AhPlA24-333 S67A D213N 61 34 
BpPlA37-496 (+DTT) 191 47 
BpPlA37-496 S230A D378N (+DTT) 178 47 
BpPlA190-496 ΔN 60 33 
RsPlA31-352 65 35 
RsPlA31-352 S89A D231N 64 35 
RsPlA48-352 pass ΔN 63 35 
FplA20-431 * 83 47 
*Casasanta et al., 2017 763 
 764 
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Table 4. Estimated molecular weight of the PlpD dimer and monomers based on the retention 765 
time of SEC. The MW of the monomeric PlpD is shown for comparative reason and was 766 
calculated in Protparam based on the respective amino acid sequence.  767 
 768 
Protein Est. MW 
[kDa] 
Est. MW Monomer 
[kDa] 
PlpD19-331 69 35 
PlpD19-331 M249E 35 - 
PlpD19-331 I253A M256D 35 - 
 769 
 770 
 771 
Table 5. Comparison of the enzymatic efficiency of the PlpD dimer and monomers at different 772 
temperatures and at pH 9. Shown are the Michaelis-Menten Kinetics using the graphing and data 773 
analysis software from OriginLab (Massachusetts, USA). ND=Not detectable. 774 
 Tmp. (⁰C) kcat (s
-1
) Km (µM) kcat/Km (s
-1
 M
-1
) 
PaPlpD19-331 25 0.07 ± 0.01 51 ± 21 1.3 x 10
3
 ± 0.6 x 10
3
 
PaPlpD19-331 37 0.3 ± 0.04 166 ± 44 1.8 x 10
3 
± 0.5 x 10
3
 
PaPlpD19-331 45 0.4 ± 0.1 186 ± 71 2.2 x 10
3
 ± 1 x 10
3
 
PaPlpD19-331 M249E 25 0.08 ± 0.01 37 ± 14 2.2 x 10
3
 ± 0.9 x 10
3
 
PaPlpD19-331 M249E 37 0.09 ± 0.01 66 ±21 1.4 x 10
3
 ± 0.5 x 10
3
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PaPlpD19-331 M249E 45 0.01 ± 0.01 118 ± 310 94 ± 2.8 x 10
2
 
PaPlpD19-331 I253A M256D 25 0.06 ± 0.006 40 ± 11 1.4 x 10
3
 ± 0.4 x 10
3
 
PaPlpD19-331 I253A M256D 37 0.09 ± 0.005 104 ± 13 8.6 x 10
2
 ± 1.2 x 10
2
 
PaPlpD19-331 I253A M256D 45 ND ND ND 
 775 
 776 
 777 
 778 
Figure legends 779 
Figure 1. Structure and sequence analysis of the lipase domains of PlpD and its homologs. 780 
A) Structure of PlpD. The two monomers of the homodimeric protein are shown in magenta and 781 
blue in cartoon representation. The flexible lid, not visible in the crystal structure, has been drawn 782 
with a dashed lined. The active site residues are shown in stick representation (S60 in yellow and 783 
D207 in green). The figure was prepared using PyMOL (Schrödinger) based on the PlpD crystal 784 
structure (PDB ID: 5FYA). 785 
B) Alignment of selected PlpD homologs. Predicted secondary structure elements are in blue (β-786 
strands) or pink (α-helices); the intensity of the color refers to the strength of the prediction. 787 
Predicted signal peptides are underlined. The catalytic residues are highlighted in red. The small 788 
residues forming the oxyanion hole are indicated in orange. The position of the flexible lid is 789 
shown by a dashed yellow line and the position of the putative linker by a dashed brown line. 790 
GenBank accession numbers for the sequences are AAG06727 (PlpD), AGM45846 (AhPlA), 791 
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ABA53592 (BpPlA), KER53746 (BfPlA), AAQ60385 (CvPlA), AAL93819 (FplA), AFJ59299 792 
(PfPlA), EAP74568 (RsPlA), AAN53510 (SoPlA), and AAF93770 (VcPlA). 793 
 794 
Figure 2. Lipolytic activity of all tested PlAs. A) Michaelis-Menten Kinetics based on 795 
fluorescence produced by the hydrolysis of the artificial substrate 4-MuH. B) Phospholipase A1 796 
(left) and A2 (right) activity using the PLA1 and PLA2-specific substrates PED-A1 and BODIPY 797 
PC-A2, respectively. Error bars denote standard deviations. Ctrl: Phospholipase A1/A2 798 
(ThermoFisher). ND=Not detectable. 799 
 800 
Figure 3. Lipid binding assays. Strips with bound lipids (indicated in the Figure) were overlaid 801 
with PlAs and then detected using an anti-His tag antibody. Catalytically inactive mutants of the 802 
PlAs were used so as not to damage the lipids, but results were comparable to catalytically active 803 
protein (Figure S4). The lipids impregnated on the left side of the strip are noted on the left in the 804 
figure, and those on the right-hand side of the strip to the right in the figure.  805 
Figure 4.Specific lipid hydrolysis by PlAs. Lipids were incubated with PlAs for 24 h. Detection 806 
of lipid digestion are shown by TLC. Lipids incubated in the absence of any PLA were used as 807 
negative control. Solvent systems used as mobile phase are mentioned below individual figures. 808 
A) Phosphatidylethanolamine (PE). B) Phosphatidylserine (PS). C) Phosphatidylinositol 4-809 
phosphate (PI(4)P). D) Soy lipid extract. 810 
Figure 5. Oligomerization of PlA passengers. A) Alignment of the dimerization interface of the 811 
different PlAs. B) SDS-PAGE of all tested PlAs in the presence and absence of the amine-amine 812 
cross-linker BS3. C) SEC of P. aeruginosa PlpD passenger as well as its homologs from A. 813 
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hydrophila, R. solanacearum and B. pseudomallei. Wt passengers are shown in red, the truncated 814 
passenger of B. pseudomallei with deletion of the N-terminal extension is shown in blue and the 815 
molecular weight standards (Vitamin B12 [1.35 kDa]; Myoglobin (horse) [17 kDa]; Ovalbumin 816 
(chicken) [44 kDa]; γ-globulin (bovine) [158 kDa]; Thyroglobulin (bovine) [670 kDa]; Biorad) 817 
are shown in grey. Signal data may have been enhanced for data presentation by factor x as 818 
indicated in [] behind the respective protein. D) Comparative overview of the multimerization 819 
status of the tested PlAs based on SEC. Indicated in white are the estimated MWs of the 820 
monomeric proteins, indicated in red are the estimated MWs based on SEC data gathered in this 821 
study, indicated with dotted lines are the expected MWs of the dimeric proteins and indicated in 822 
shades of grey are the expected MWs of the BpPlA dimer, trimer and tetramer (dimer-dimer). 823 
Calculated and expected MWs are shown in Table 3. 824 
 825 
Figure 6. Mutation of the dimerization interface of the PlpD homodimer leads to disruption of 826 
the homodimer. A) Dimerization interface of two neighboring molecules in the homodimer of 827 
PlpD (PDB: 5FYA). B) SEC of the PlpD dimer (red) and its monomeric forms, PlpD M249E 828 
(blue) and PlpD I253E M256D (green). Shown in grey are the molecular weight standards 829 
(Vitamin B12 [1.35 kDa]; Myoglobin (horse) [17 kDa]; Ovalbumin (chicken) [44 kDa]; γ-830 
globulin (bovine) [158 kDa]; Thyroglobulin (bovine) [670 kDa]; Biorad). C) Cross-linking of 831 
dimeric PlpD using the amine-amine cross-linker BS3. 832 
 833 
Figure 7. Homodimer-formation by PlpD is not necessary for activity. A) Michaelis-Menten 834 
kinetics of the PlpD dimer and monomers (PlpD M249E and PlpD I253A M256D) at 25⁰C, 37⁰C 835 
39 
 
and 45⁰C. The working concentration of PlpD, PlpD M249E and PlpD I253A M256D were 1 µM, 836 
100 nM and 100 nM, respectively. B) Phospholipase activity 1 of the PlpD dimer compared to 837 
the monomers. See legend of Figure 2 for full description. 838 
 839 
 840 
 841 
 842 
 843 
 844 
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Figure S1. PlAs Burkholderia sp. have an N-terminal extension  
Alignment of PlA passenger N-terminal sequences from Burkholderia strains. All 
Bulkholderiae have an N-terminal extension, but only PlAs from B. pseudomallei and B. 
mallei have one longer than ~40 residues. Genbank accession numbers for the sequences are 
ABA53592 (Bp 1710b), WP_011857657 (Bp 1106b), AFI68957 (Bp 1026b), AFR18824 (Bp 
BPC006), AGR68910 (Bp MSHR305), AGZ32405 (Bp NCTC 13179), YP_110653 (Bp 
K96243), YP_001078772 (Bp NCTC 10247), ABN86253 (Bp 668), YP_105527 (Bm ATCC 
23344), WP_011831963 (Bm NCTC 10229), AGK50760 (Bt MSMB121), AIP28840 (Bt 
E264), AFQ49895 (Bc GG4), ABB10869 (Bl), CAR56030 (Bcpc J2315), ACA94478 (Bcpc 
MC0-3), ABK11671 (Bcpc HI2424), ABF78326 (Bcpc AU 1054), and ABX17368 (Bmu 
ATCC 171616). 
 
Figure S2. BpPlA and RsPlA degradation product 
A) Degradation of PlAs noticed during protein purification in the case of BpPlA (left) and 
RsPlA (right) B) Degradation of RsPlA and BpPlA at different time points and different 
temperatures after sample defrosting. Freshly defrosted sample was used as control. C) Low 
molecular weight bands are degradation products of BpPlA and RsPlA, respectively. 
Confirmed by mass spectrometric analysis. 
 
Figure S3. pH and temperature optima of target PlAs 
pH (left) and temperature range (right) of target PlAs based on Michaelis-Menten kinetics 
using the artificial lipid substrate 4-MuH. 
 
 
Figure S4. Comparison of lipid binding between PlpD and PlpD S60A D207N 
Lipid binding assays. Mutation of the catalytic dyad has no major effect on lipid binding. 
Strips with bound lipids (indicated in the Figure) were overlaid with wildtype PlpD (right) or 
inactive PlpD (left) and then detected using an anti-His tag antibody. The lipids impregnated 
on the left side of the strip are noted on the left in the figure, and those on the right-hand side 
of the strip to the right in the figure.  
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Figure S5. A) SDS-PAGE of BS3 crosslinked PlAs. Highlighted in red are high molecular 
weigth bands (A1-G2) chosen for MS. B) MS data confirming PlA nature of high molecular 
weight bands, labelled A1-G2, observed in the PlA crosslinking experiment. Reference 
sequence indicated above the individual result. Peptides detected by MS shown in yellow. 
 
 
 
Table S1. Direct toxic effect of AhPlA, BpPlA, FplA and PlpD. Shown is the percental survival of Galleria mellonella. LD50(AhPlA)=509 μg/g; 
LD50(BpPlA)=13,9 mg/g. 
Days past infection 
 
AhPlA 
 
AhPlA 
S67A D213N 
BpPlA 
  
BpPlA 
S230A D378N 
FplA 
 
PlpD 
 
PBS 
 
Conc./Bodyweight [μg/g] 2 20 200 200 2 20 200 200 1,25 12,5 125 400 - 
n 8 16 15 10 8 16 18 13 8 8 8 8 5 
0 100 100 100 100 100 100 94 100 100 100 100 100 100 
1 100 88 87 100 100 88 89 92 100 100 100 100 100 
2 100 88 73 100 100 88 89 92 100 100 100 100 100 
3 100 81 73 100 100 81 89 92 100 100 100 100 100 
4 100 81 73 100 100 81 83 92 100 100 100 100 100 
5 100 75 60 100 100 81 78 92 100 100 100 100 100 
 
